Glucagon-like peptide-1 (GLP-1) receptor agonists are FDA-approved medications for type 2 diabetes and weight management, but currently no GLP-1 patches are approved for use in the United States
These include IV therapy, fat-burning shots, infrared therapy, body assessments, and Emsculpt sessions
Most insurance plans, including Medicare and commercial plans, only cover FDA-approved brand-name or generic medications, and compounded medications fall outside standard insurance formularies
doi: 10.3109/13880209.2012.656847 12
There is no established upper-limit toxicity for oral B12
Consider transferring remaining peptide to fresh containers or using parafilm as supplemental sealing